Platinum Equity Acquires Controlling Stake in Inventia Healthcare

Platinum Equity has acquired a controlling stake in Inventia Healthcare Limited's core Oral Solid Dosage (OSD) business from India Life Sciences Fund III (advised by InvAscent), NYLIM Jacob Ballas India Fund III and affiliates of the founding Shah family, with the Shah family retaining a minority stake. Headquartered in Mumbai, Inventia is a U.S. FDA- and MHRA-accredited contract manufacturer and developer of generic OSD products serving more than 100 customers across 40+ countries; Platinum plans to expand the business organically and via add-on acquisitions.